Publication: Neuroblastoma Occurring in Nijmegen Breakage Syndrome
| dc.contributor.author | Djurisic, Marina (12769932200) | |
| dc.contributor.author | Sarajlija, Adrijan (26027638400) | |
| dc.contributor.author | Radivojevic, Danijela (12769357500) | |
| dc.contributor.author | Cirkovic, Sanja (56627166200) | |
| dc.contributor.author | Djokic, Dragoljub (36619461900) | |
| dc.contributor.author | Djuricic, Slavisa (6603108728) | |
| dc.contributor.author | Samardzija, Gordana (56177152500) | |
| dc.contributor.author | Pasic, Srdjan (55904557400) | |
| dc.date.accessioned | 2025-06-12T11:38:02Z | |
| dc.date.available | 2025-06-12T11:38:02Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Nijmegen breakage syndrome (NBS) is a rare primary immunodeficiency disease due to a pathogenic variant in the NBN gene causing impaired DNA repair and increased predisposition for lymphoid malignancy. By contrast, solid tumors have been rarely reported. Neuroblastoma (NB) is a rare childhood solid tumor, associated with the worse outcome if MYCN oncogene is amplified. We describe 2 young pediatric patients with NBS who developed high-risk NB. The first patient died shortly after chemotherapy was introduced. The second patient successfully received modified chemotherapy resulting in clinical remission lasting 2 years after an initial diagnosis of NB. © 2024 Wolters Kluwer Health, Inc. All rights reserved. | |
| dc.identifier.uri | https://doi.org/10.1097/MPH.0000000000002965 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85210306734&doi=10.1097%2fMPH.0000000000002965&partnerID=40&md5=9473206e1d8acd2f249bd40850c29216 | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/658 | |
| dc.subject | DNA damage response | |
| dc.subject | MYCN amplification | |
| dc.subject | NBN gene | |
| dc.subject | neuroblastoma | |
| dc.subject | Nijmegen breakage syndrome | |
| dc.title | Neuroblastoma Occurring in Nijmegen Breakage Syndrome | |
| dspace.entity.type | Publication |
